National Health Investors, Inc.
NHI
$84.07
-$3.61-4.12%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.29M | 62.18M | 70.27M | 68.87M | 65.78M |
| Total Other Revenue | 37.19M | 27.74M | 21.92M | 20.85M | 19.97M |
| Total Revenue | 107.48M | 89.92M | 92.19M | 89.71M | 85.76M |
| Cost of Revenue | 26.00M | 18.86M | 11.92M | 13.73M | 13.60M |
| Gross Profit | 81.48M | 71.06M | 80.27M | 75.99M | 72.15M |
| SG&A Expenses | 7.61M | 6.45M | 7.22M | 8.26M | 5.83M |
| Depreciation & Amortization | 21.65M | 20.22M | 19.92M | 19.16M | 18.68M |
| Other Operating Expenses | 324.00K | 244.00K | 243.00K | 269.00K | 94.00K |
| Total Operating Expenses | 55.59M | 45.77M | 39.30M | 41.41M | 38.20M |
| Operating Income | 51.89M | 44.15M | 52.89M | 48.30M | 47.55M |
| Income Before Tax | 37.80M | 32.48M | 36.69M | 33.82M | 42.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.80M | 32.48M | 36.69M | 33.82M | 42.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 360.00K | 384.00K | 298.00K | 348.00K | 455.00K |
| Net Income | 38.16M | 32.86M | 36.99M | 34.17M | 43.24M |
| EBIT | 51.89M | 44.15M | 52.89M | 48.30M | 47.55M |
| EBITDA | 73.54M | 64.37M | 72.81M | 67.46M | 66.23M |
| EPS Basic | 0.80 | 0.69 | 0.79 | 0.75 | 0.96 |
| Normalized Basic EPS | 0.50 | 0.41 | 0.50 | 0.47 | 0.46 |
| EPS Diluted | 0.80 | 0.69 | 0.79 | 0.74 | 0.95 |
| Normalized Diluted EPS | 0.50 | 0.41 | 0.49 | 0.47 | 0.45 |
| Average Basic Shares Outstanding | 47.65M | 47.43M | 46.69M | 45.72M | 45.12M |
| Average Diluted Shares Outstanding | 47.88M | 47.62M | 46.82M | 45.88M | 45.44M |
| Dividend Per Share | -- | 0.92 | 0.90 | 0.90 | 0.90 |
| Payout Ratio | 114.84% | 130.01% | 113.62% | 120.35% | 90.79% |